Published in
Elsevier, Lung Cancer, (136), p. 74-79, 2019
DOI: 10.1016/j.lungcan.2019.08.011
Links
Tools
An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer
Journal article published in 2019 by
Daniel Morgensztern,
Nina Karaseva,
Enriqueta Felip,
Ignacio Delgado,
Olga Burdaeva,
Manuel Dómine,
Primo Lara,
Paul K. Paik,
Ulrik Lassen 
,
Sergey Orlov ,
José Trigo ,
Marina Shomova,
Katherine Baker-Neblett,
James Vasquez,
Xiaowei Wang
and other authors.
,
Sergey Orlov ,
José Trigo ,
Marina Shomova,
Katherine Baker-Neblett,
James Vasquez,
Xiaowei Wang
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 